Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | ||
Ligand | BDBM285626 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Scintillation Proximity Assay (SPA) | ||
IC50 | 4.58±n/a nM | ||
Citation | Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM Imidazopyridazine compounds US Patent US9598421 Publication Date 3/21/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | |||
Name: | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | ||
Synonyms: | 3',5'-cyclic phosphodiesterase | DPDE2 | PDE46 | PDE4A | PDE4A_HUMAN | Phosphodiesterase 4 (PDE4) | Phosphodiesterase 4A | Phosphodiesterase 4A (PDE4) | ||
Type: | Enzyme | ||
Mol. Mass.: | 98113.27 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P27815 | ||
Residue: | 886 | ||
Sequence: |
| ||
BDBM285626 | |||
n/a | |||
Name | BDBM285626 | ||
Synonyms: | 3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide | US10077269, Example 96 | US10669279, Example 96 | US9598421, Example 96 | ||
Type | Small organic molecule | ||
Emp. Form. | C15H11ClF2N4O | ||
Mol. Mass. | 336.724 | ||
SMILES | CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)| | ||
Structure |